These growth supplementation studies suggest that while GCN2 is indispensable for maintaining EAA in PCa cells, the precise processes by which GCN2 carries out these functions can vary among PCa cell lines presumably due to differences in their unique genetic features and cell-line-specific buffering mechanisms accompanying specific gene expression and metabolic programs. The gene discussed is EIF2AK4; the disease is posterior cortical atrophy.